Sep 2, 2015 ... limited to one such submission for all plaintiffs and one such ..... ARMSTRONG, ET AL. v. .... Pharmaceuticals, Inc., Janssen Research & Development, LLC, ... Meunier and Leonard A. Davis are well qualified to carry out the ...
Olson et al v. Janssen Research & Development LLC et al Court: Louisiana Eastern District Court Case Num: 2:19-cv-00283. Filed: Jan 15, 2019. Nature of suit: ...
Oct 12, 2016 ... ... Allen v. Janssen Pharmaceuticals, Inc., et al., Case No. 3:15- ... Janssen Research & Development LLC, No. ..... 1:16-cv-08838: Joy Davis vs.
JANSSEN PHARMACEUTICALS INC JOHNSON JOHNSON JANSSEN RESEARCH ... and Janssen Research & Development, LLC, have taken cross- appeals from the judgment entered in ... All of the cases in this mass tort involve male plaintiffs who allege they developed ..... Parke, Davis & Co., 679 N.W.2d 867, 876 (Wis.
Dec 21, 2017 ... CAR-T BCMA in Development for Patients with Multiple Myeloma. ... M.D., Ph.D., Global Therapeutic Area Head, Oncology, Janssen Research & Development, LLC. ... ,While some patients with myeloma have no symptoms at all, most patients are diagnosed due to ... Linda Davis ...  Kumar, SK et al.
Explore Janssen's innovative medical research and development practices, and see how Janssen is dedicated to the well-being of patients around the world.
Dec 7, 2016 ... Invokana and its sister drug Invokamet belong to a class of. 2 diabetes drugs .... DAVIS v. JANSSEN PHARMACEUTICALS, INC., C.A. No. 1:16-08838 ... JANSSEN RESEARCH & DEVELOPMENT LLC, ET AL., C.A. No. 3:16- ...
... of America et al v. Janssen Pharmaceutical N.V. et al, case number 2:16-cv- 06997, from California Central Court. ... Janssen Research and Development, LLC ...
Feb 3, 2018 ... Open AccessPharmacokinetics and Exposure Response ...... and Hugh M. Davis are employees of Janssen Research & Development, LLC.